Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.9637
+0.0880 (10.05%)
Aug 22, 2025, 4:00 PM - Market closed
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $10.28 million as of August 22, 2025. Its market cap has increased by 72.66% in one year.
Market Cap
10.28M
Enterprise Value
8.04M
1-Year Change
72.66%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $35.28M to $10.28M, a decrease of -70.86%. That is a compound annual growth rate of -27.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 10.28M | 21.72% |
| Dec 31, 2024 | 8.45M | 100.93% |
| Dec 29, 2023 | 4.20M | -82.82% |
| Dec 30, 2022 | 24.47M | -80.97% |
| Dec 31, 2021 | 128.63M | 264.59% |
| Oct 29, 2021 | 35.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |